Within the Federal Ministry of Education and Research (BMBF) network “MND-NET”, a pilot study on the feasibility of internet-based patient-reported outcomes (PRO) of disease progression, quality of life and communication options for patients with amyotrophic lateral sclerosis (ALS) in Germany (PRO-ALS01 study) is planned.
The PRO-ALS01 study is being conducted nationwide at the university hospitals in Berlin, Bochum, Hanover, Jena and Ulm. The internet-based recording of treatment results is carried out via AmbulanzPartner.de. The ethics committee of Charite – Universitätsmedizin Berlin has approved the ethics application for this healthcare research study, meaning that recruitment for the study can now begin.
On December 4, 2025, the ALS app will be presented at the"ALS App Europe Initiative…
Following our last newsletter on the introduction of the OPM classification in the ALS app,…
You can now submit your e-prescription with your health card via the ALS app at…
We are pleased to introduce an important new feature in the ALS app today: The…
The THC:CBD patient survey is a systematic survey of 130 patients with amyotrophic lateral sclerosis…
We are pleased to inform you that we have completely revised our medication module. With…